相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma
Dong Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Present Status and Problems on Molecular Targeted Therapy of Cancer
Nagahiro Saijo
CANCER RESEARCH AND TREATMENT (2012)
Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2
Hyunho Yoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy
Yan Shi et al.
TUMOR BIOLOGY (2011)
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Huadong Pei et al.
CANCER CELL (2009)
Tumour cell survival signalling by the ERK1/2 pathway
K. Balmanno et al.
CELL DEATH AND DIFFERENTIATION (2009)
ERK/BCL-2 Pathway in the Resistance of Pancreatic Cancer to Anoikis
Joseph M. Galante et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
Barry Fine et al.
SCIENCE (2009)
AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition
Simona Caporali et al.
MOLECULAR PHARMACOLOGY (2008)
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
Michael Fraser et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC
Paolo Maione et al.
ONCOLOGIST (2006)
PKC 412 sensitizes U1810 non-small cell lung cancer cells to DNA damage
TH Hemström et al.
EXPERIMENTAL CELL RESEARCH (2005)
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003
DG Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
